or Try an Advanced Search...

    Diabetic Nephropathy Stocks List

    Symbol Grade Name % Change
    LABP A Landos Biopharma, Inc. 0.87
    MESO B Mesoblast Limited 8.50
    CYCN D Cyclerion Therapeutics, Inc. 0.00
    BMY F Bristol-Myers Squibb Company -0.31
    XRTX F XORTX Therapeutics Inc. -2.00
    AMPE F Ampio Pharmaceuticals, Inc. -16.13
    ZVSA F ZyVersa Therapeutics, Inc. -2.11
    INCY F Incyte Corporation -0.52
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Kidney Disease Medicine Organ Systems Rheumatoid Arthritis Autoimmune Disease Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences S&P 500 Abdominal Pain Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autosomal Dominant Polycystic Kidney Disease Back Pain

    Related ETFs - A few ETFs which own one or more of the above listed Diabetic Nephropathy stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 8.21
    MEDX F Horizon Kinetics Medical ETF 5.43
    IHE C iShares U.S. Pharmaceutical ETF 4.4
    XPH D SPDR S&P Pharmaceuticals ETF 4.3
    PPH C Market Vectors Pharmaceutical ETF 4.29
    View all Diabetic Nephropathy ETFs...
    Compare ETFs
    Compare FTXH to PPH Compare IHE to PPH Compare XPH to PPH

        Diabetic Nephropathy Stocks Recent News

        Date Stock Title
        Apr 23 INCY Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
        Apr 23 BMY S&P 500 stocks with biggest estimated EPS declines for Q1
        Apr 23 INCY Incyte (INCY) Earnings Expected to Grow: Should You Buy?
        Apr 23 BMY NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
        Apr 23 INCY Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
        Apr 23 BMY Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook
        Apr 23 BMY Former Bristol Myers CEO tapped as Novartis’ next board chair
        Apr 23 INCY Incyte to acquire immune-focused drug developer Escient
        Apr 23 INCY Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
        Apr 22 BMY Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
        Apr 22 BMY Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal
        Apr 22 BMY Is Bristol Myers Squibb A Buy At These Bottom Levels?
        Apr 22 BMY Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
        Apr 22 BMY Bristol Myers taps startup to boost cell therapy production
        Apr 22 XRTX XORTX Announces Publication of Key Research in ADPKD
        Apr 22 BMY Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
        Apr 21 BMY Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
        Apr 21 BMY Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
        Apr 20 BMY 3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations
        Apr 19 BMY Got $500? 3 Healthcare Stocks to Buy and Hold Forever
        Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Kidney Disease Medicine Organ Systems Rheumatoid Arthritis Autoimmune Disease Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences S&P 500 Abdominal Pain Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autosomal Dominant Polycystic Kidney Disease Back Pain
        Diabetic Nephropathy

        Diabetic nephropathy is a type of kidney disease that is caused by damage to the blood vessels in the kidneys due to diabetes. It is a serious complication of diabetes and can lead to kidney failure. Symptoms of diabetic nephropathy include high blood pressure, swelling in the legs and feet, and protein in the urine. Treatment for diabetic nephropathy includes controlling blood sugar levels, taking medications to reduce blood pressure, and following a healthy diet.

        Browse All Tags